xl-130

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug Namexl-130
Drug Alias NamePAS-IL1Ra
ClassificationBiologics
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXL-protein GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXL-protein GmbH
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A